Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

buserelin

A synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. Prolonged administration of buserelin results in sustained inhibition of gonadotropin production, suppression of testicular and ovarian steroidogenesis, and reduced levels of circulating gonadotropin and gonadal steroids. Buserelin is more potent that GnRH.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:buserelin acetate
busereline
US brand name:Etilamide
Foreign brand name:Bigonist
Profact
Profact Depot
Receptal
Suprecur
Suprefact
Suprefact Depot
Suprefact Flakon
Abbreviation:BSRL
Code name:HOE 766
ICI 123215
S74-6766
Chemical structure:6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig)
D-ser (bu(t))(6) pro(9) NEt LHRH Acetate
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search